Global Duck Vaccines Market Size By Product Type (Live Vaccines, Killed Vaccines), By Application (Avian Influenza Vaccine, Newcastle Disease Vaccine), By Geographic Scope And Forecast
Published on: 2024-08-06 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Duck Vaccines Market Size By Product Type (Live Vaccines, Killed Vaccines), By Application (Avian Influenza Vaccine, Newcastle Disease Vaccine), By Geographic Scope And Forecast
Duck Vaccines Market Size And Forecast
Duck Vaccines Market size was valued at USD 1777.0 Million in 2021 and is projected to reach USD 2992.10 Million by 2030, growing at a CAGR of 5.96 % from 2023 to 2030.
Increasing investment in R&D programs for the development of several preventive vaccines and guidelines provided by regulatory bodies associated with species health for Duck treatment are the major factors expected to stimulate the global Duck Vaccines Market. The Global Duck Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Duck Vaccines Market Definition
“Diseases such as the duck plague (DP) is a severe disease among ducks. Control of the disease is recognized as one of the biggest challenges in avian medicine. Vaccines for such diseases are an efficient method of prevention. The Duck Vaccines Market report is segmented on the basis of type and application. By type, the market is segmented into Live vaccines and Killed Vaccines. The application segment is bifurcated into the Avian Influenza Vaccine, the Newcastle Disease Vaccine, and Others. Older birds are more susceptible to bacterial infections.
It is characterized by damage to the blood vessels with bleeding tissue and free blood in the body’s arteries. Intestinal Lumina and gizzard get full of blood. There is no cure for this disease. The birds can be protected by the Duck Plague Vaccine, native to the country, given at the age of 8 to 12 weeks. Duck plague can be prevented by vaccination but, no treatment for these bacterial infections is available and secondary infections should be prevented.
Over the past two decades, the Duck Vaccines Market has grown at an enormous scale, and over time it has brought many challenges with the change in the structure of the company and the way employees behave. The global Duck Vaccines Market is undergoing significant changes, as the manufacturers need to evolve in an attempt to keep the structure of their work.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Duck Vaccines Market Overview
Increasing investment in R&D programs for the development of several preventive vaccines and guidelines provided by regulatory bodies associated with species health for Duck treatment are the major factors expected to stimulate the global Duck Vaccines Market. Developing technologically advanced healthcare infrastructure and ongoing research projects in association with international universities and prominent vendors for the development of effective vaccines will provide lucrative growth opportunities to the global Duck Vaccines Market. However, the global Duck Vaccines Market faces challenges as a large percentage of the global population predominantly in developing economies is yet to have its hands on these vaccines. With the increase in the number of foreign travels, cross migrations and other travels all over the world, including a growing population there is a need for the widespread manufacturing of these vaccines.
However, the high costs associated with the operation and maintenance of facilities in the sector will be a hindrance to the growth of the market. In addition, the lack of qualified specialists will challenge the growth of the market. Excess of unstructured data is expected to slow economic growth. The increasing complexity of interconnecting electronic components, the drop in global commodity prices, and the recent outbreak of COVID-19 have brought up many challenges to Duck Vaccines Market. Nevertheless, rising demand for networking and storage devices in the data center, demand for smart healthcare infrastructure, robotics in healthcare applications, and sensor-based devices are expected to provide huge opportunities for the Duck Vaccines Market for the forecasted period.
Global Duck Vaccines Market Segmentation Analysis
The Global Duck Vaccines Market is Segmented on the basis of Product Type, Application, And Geography.
Duck Vaccines Market, By Product Type
- Live Vaccines
- Killed Vaccines
Based on Product Type, the market is bifurcated into Live Vaccines and Killed Vaccines. Live Vaccines are those vaccines in which the virus causing disease is weakened and slowly develop body immunity. Killed Vaccines or Inactivated vaccines have grown viruses, bacteria, or pathogens which are then killed to stop the disease-producing agent.
Duck Vaccines Market, By Application
- Avian Influenza Vaccine
- Newcastle Disease Vaccine
- Other
Based on Application, the market is bifurcated into Avian Influenza Vaccine, Newcastle Disease Vaccine, and Other. Avian Influenza Vaccine is the largest contributor to the global market in 2021 in this segment and is very likely to continue the trend in the forecast period.
Duck Vaccines Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
Based on regional analysis, the Global Duck Vaccines Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The North American region dominated the global market in 2021 followed by Europe and is expected to continue the trend in the forecast period. The Asia Pacific region is expected to grow at a rapid pace in the forecast period owing to rapid urbanization and industrialization with an increased investment towards smart & efficient technology and increased per capita income.
Key Players
The “Global Duck Vaccines Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as are GMerial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, ChengDu Tecbond. among others.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Duck Vaccines Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Duck Vaccines Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2018-2030 |
BASE YEAR | 2021 |
FORECAST PERIOD | 2023-2030 |
HISTORICAL PERIOD | 2018-2020 |
UNIT | Value (USD Million) |
KEY COMPANIES PROFILED | GMerial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health. |
SEGMENTS COVERED |
|
CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.